The Procter & Gamble Company (NYSE:PG) Shares Bought by IQ EQ FUND MANAGEMENT IRELAND Ltd

IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 2.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 41,265 shares of the company’s stock after buying an additional 944 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Procter & Gamble were worth $7,147,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PG. Wulff Hansen & CO. lifted its stake in shares of Procter & Gamble by 16,292.0% in the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after purchasing an additional 3,653,477 shares during the last quarter. TD Asset Management Inc lifted its stake in shares of Procter & Gamble by 114.9% in the 1st quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after purchasing an additional 1,907,716 shares during the last quarter. AMF Tjanstepension AB lifted its stake in shares of Procter & Gamble by 416.1% in the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after purchasing an additional 1,466,115 shares during the last quarter. Swedbank AB acquired a new position in shares of Procter & Gamble in the 1st quarter valued at $233,788,000. Finally, Ilex Capital Partners UK LLP acquired a new position in shares of Procter & Gamble in the 1st quarter valued at $228,212,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the completion of the sale, the insider now directly owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock valued at $65,140,718 in the last three months. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Trading Down 0.7 %

PG opened at $172.36 on Thursday. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The company has a market cap of $406.78 billion, a P/E ratio of 28.16, a PEG ratio of 3.67 and a beta of 0.41. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The business’s 50-day simple moving average is $171.72 and its 200-day simple moving average is $167.00.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business’s revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.37 EPS. As a group, equities research analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.34%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Analyst Ratings Changes

Several brokerages have recently commented on PG. JPMorgan Chase & Co. upped their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Royal Bank of Canada boosted their price objective on Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a report on Wednesday, July 31st. Deutsche Bank Aktiengesellschaft boosted their price objective on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. TD Cowen started coverage on Procter & Gamble in a report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. Finally, Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and cut their price target for the stock from $182.00 to $175.00 in a report on Wednesday, July 24th. Nine investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $176.21.

Get Our Latest Stock Analysis on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.